Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Disney CEO to step down
Worker dragged under train
Tony-winning actress dies
‘I don’t want to die’
Divorce after 7 years
Split after welcoming baby
Quits 'I'm A Celebrity'
‘It was a perfect day’
'SNL' sets last 2023 hosts
Kelce’s nickname for Swift
Reveals ectopic pregnancy
Nixon joins hunger strike
Threatened with extinction
Acquiring Rover for $2.3B
Defamation suit refiled
1st trip to Shanghai in 3 yrs
In talks to merge with Humana
RU mulls 'loyalty pledge’
Panthers sign Jackson
SDSU hires Sean Lewis
Guide to Spotify Wrapped
Nepal's 1st gay marriage
Sued for Binance promotion
'Friends' viewership rockets
Trims annual sales forecast
2-year deal with Reds
'Ted' series trailer
Shares jump more than 10%
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
4,840 results
11don MSN
How well-off Brits still buy Ozempic online for weight loss
Britain prevents Ozempic reaching people who want to lose weight because of a national semaglutide shortage. But some pay ...
Forbes21d
Does Medicare Cover Ozempic?
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.
14hon MSN
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
Don't expect sales for Ozempic and Wegovy to crater anytime soon, though. Novo Nordisk has a solid head start in the market.
WGRZ22d
Prescriptions for ketamine have soared in recent years, despite little research or regulation
Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions.
Medscape29d
Semaglutide Prescribing Surged in the Past Year
Prescriptions for semaglutide jumped 150% in the past year, with an 80% increase in prescriptions written per provider, new data suggest. Among more than 350,000 prescribers in the nationwide ...
Medscape12d
Comparison of State Requirements for Preprinted Prescriptions
Many pharmacists are uncertain about how to deal with pre-printed prescriptions: prescription pads preprinted with the drug name, quantity, and, less frequently, directions for use. Although these ...
Time22d
Should We End Obesity?
It’s unusual for a medication to become a household name; even more uncommon for its branding to become, like Advil, shorthand for an entire class of products; and rarest of all, for it to ...
TheStreet.com21d
Beloved fast-food chain files for Chapter 11 bankruptcy
Iconic and essential retailers have been marching into bankruptcy court this year as issues related to supply chain disruptions, rising inflation and other financial difficulties pushed many into ...
New York Post22d
Woman dies after taking Ozempic to slim down for daughter’s wedding: ‘She shouldn’t be gone’
Trish Webster, 56, was prescribed Ozempic to help her squeeze into her dream dress for her daughter’s nuptials. Ozempic is a medication approved by the US Food and Drug Administration for people ...
Wall Street Journal27d
Eli Lilly, Novo Nordisk See High Demand for Anti-Obesity Drugs Wegovy, Ozempic
Drugmakers Eli Lilly and Novo Nordisk both reported strong third-quarter sales growth Thursday, citing the performance of the GLP-1 class of diabetes and anti-obesity drugs that are in high demand.
Yahoo1mon
These 15 metro areas saw biggest jumps in Ozempic use. They might not be where you expect.
A diabetes medication in short supply for the last two years often was prescribed to people who didn't have the disease, and prescribing rates varied dramatically across the country, new data shows.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices